A Day Up For Corvus Pharmaceuticals, Inc.
Tue, Dec 03, 2019 at 05:30 PM
Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ) jumped higher at $4.47, representing a gain of 41%. On Mon 02 Dec 19, CRVS:NASDAQ touched a New 2-Week High of $3.17. The stock appeared on our News Catalysts scanner on Fri 08 Nov 19 at 07:38 AM in the 'BIOTECH' category. From Mon 11 Nov 19, the stock recorded 57.14% Up Days and 46.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ)
Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is engaged in development and commercialization of novel immuno-oncology therapies that are designed to harness the immune system to attack cancer cells.
Top 10 Gainers:
- Audentes Therapeutics, Inc. (BOLD:NASDAQ), 105.98%
- Quorum Health Corporation (QHC:NYSE), 65%
- Outlook Therapeutics, Inc. (OTLK:NASDAQ), 54.37%
- Motif Bio plc (MTFB:NASDAQ), 50.05%
- DarioHealth Corp. (DRIO:NASDAQ), 49.1%
- Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ), 47.06%
- iBio, Inc. (IBIO:NYSEMKT), 41.35%
- Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ), 41.01%
- Spirit Realty Capital, Inc. (SRC:NYSE), 40%
- Akerna Corp. (KERN:NASDAQ), 37.97%